sydnexis crl fda_thumbnail
October 28, 2025

Sydnexis Receives FDA Complete Response Letter for SYD-101 Pediatric Myopia Treatment

It’s not the “yes” Sydnexis hoped for…but it’s not a “no,” either.  The U.S. Food and Drug Administration (FDA) has…

Glasses deflecting rainbow light rays
October 10, 2025

SightGlass Vision Reports 18-month DOT Lens Data Showing Reduced Myopia Progression

New readout at Academy ’25 adds weight to contrast-modulating spectacle lenses SightGlass Vision (San Ramon, CA, United States) brought fresh…

latest posts
sydnexis crl fda_thumbnail
October 28, 2025

Sydnexis Receives FDA Complete Response Letter for SYD-101 Pediatric Myopia Treatment

Glasses deflecting rainbow light rays
October 10, 2025

SightGlass Vision Reports 18-month DOT Lens Data Showing Reduced Myopia Progression

myopia_profile_thumbnail
September 26, 2025

Myopia Management Gets a New AI Colleague: Meet ‘Ask Kate’

myopia_in_finland_thumbnail
September 22, 2025

Finland Holds the Line on Myopia While the World Blinks

gen z contacts_thumbnail
September 17, 2025

Gen Z Is Set to Drive Contact Lens Adoption. Here’s What the Industry Needs to Watch

unnamed (17)
July 3, 2025

Myopia Correction, Control and Management–What’s the Difference, and Why It Matters

Myopia biomarker thumbnail v3
June 19, 2025

A New Biomarker for Myopia Progression? Fundus Refraction Offset’s Predictive Power 

WSPOS 2025 Consensus Statement
June 11, 2025

WSPOS Myopia Consensus Statement 2025: What Parents and Practitioners Need to Know

Discover our fascinating content at issuu

explore